Alimera Sciences: 2Q Earnings Snapshot

July 30, 2018

ALPHARETTA, Ga. (AP) _ Alimera Sciences Inc. (ALIM) on Monday reported a loss of $4 million in its second quarter.

On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 6 cents.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 6 cents per share.

The eye drug developer posted revenue of $10.9 million in the period.

In the final minutes of trading on Monday, the company’s shares hit $1.11. A year ago, they were trading at $1.47.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALIM at https://www.zacks.com/ap/ALIM

Update hourly